| Patents for C07D 491 - Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups , , or (29,726) |
|---|
| 03/03/2005 | US20050049187 Reacting macrocyclic amide compound with hydroxy naphthalene or hydroxy quinoline derivative in a polar non-protic organic solvent in the presence of an organic or inorganic base |
| 03/02/2005 | EP1510510A1 Method of substituent introduction through halogen-metal exchange reaction |
| 03/02/2005 | EP1509537A2 Cellular accumulation of phosphonate analogs of hiv protease inhibitor compounds and the compounds as such |
| 03/02/2005 | EP1509529A2 Esters in position 20 of camptothecins |
| 03/02/2005 | EP1509528A2 1,3-diaza-dibenzoazulenes as inhibitors of tumour necrosis factor production and intermediates for the preparation thereof |
| 03/02/2005 | EP1509518A1 Calcium receptor modulating agents |
| 03/02/2005 | EP1509515A2 Substituted 4-aryl-4h-pyrrolo 2,3-h chromenes and analogs as activators of caspases and inducers of apoptosis and the use thereof |
| 03/02/2005 | EP1509225A1 Method for the use of pyranoindole derivatives to treat infection with hepatitis c virus |
| 03/02/2005 | EP1238979B1 Fused heterotricyclic compounds, process for preparing the compounds and drugs containing the same |
| 03/02/2005 | EP1144416B1 Heterocyclically anellated indenochromene derivatives |
| 03/02/2005 | EP1077698B1 Metabolites of ecteinascidin 743 |
| 03/02/2005 | EP0948499B1 Heteroarylsulfonamide derivatives and pharmaceutical compositions containing them |
| 03/02/2005 | CN1589271A Fused heterocyclic succinimide compounds and analogs thereof as modulators of nuclear hormone receptor function |
| 03/02/2005 | CN1589268A Substituted benzopyrans compounds as selective estrogen receptor-beta agonists |
| 03/02/2005 | CN1587265A 10-alkoxy camptothecine derivative and its preparing method and use |
| 03/01/2005 | US6861439 Treatment of cerebrovascular disease |
| 03/01/2005 | US6861434 Dopaminergic neurotransmission modulators |
| 02/24/2005 | WO2005016919A1 Aminopyrones and their use as atm inhibitors |
| 02/24/2005 | WO2005016913A1 Tetrahydroisoquinoline or isochroman compounds as orl-1 receptor ligands for the treatment of pain and cns disorders |
| 02/24/2005 | WO2005016264A2 Diamine derivatives of quinone and uses thereof |
| 02/24/2005 | WO2005016255A2 Substituted tetrahydroquinolines, phenylacetic acids and benzoic acids as hepatocyte nuclear factor 4 (hnf-4 ) modulator compounds |
| 02/24/2005 | WO2005007084A3 Pancratistatin cyclic phosphate prodrugs an phenpanstatin cyclic phosphate prodrugs |
| 02/24/2005 | WO2005005431A3 7-polyaminoalkyl(oxy)iminomethylcamptothecins bearing protective groups |
| 02/24/2005 | WO2004087056A3 BI-CYCLIC PYRIMIDINE INHIBITORS OF TGFβ |
| 02/24/2005 | WO2004078712A3 Isoquinoline derivatives and methods of use thereof |
| 02/24/2005 | US20050043387 Tricyclic indole compounds having an affinity against serotonin receptors |
| 02/24/2005 | US20050043347 N-94-94-amino-7-(3-(dimethylamino)-1-propynyl)thieno93,2-c)pyridin-3-yl)phenyl-N'-(3-methylphenyl)urea; controlling cell differentiation, cell proliferation or metabolism; anticancer agents; antidiabetic agents; antiinflammatory agents |
| 02/24/2005 | US20050043308 Process for total synthesis of ecteinascidins and intermediates therefor |
| 02/24/2005 | US20050043298 Useful for treating or preventing a variety of antibiotic resistant microbial infections; for example, 3'-hydroxy-5'-(4-ethylcarbamyl-1-piperidinyl)benzoxazinorifamycin |
| 02/24/2005 | US20050042407 containing a cyanovinylene group; can be written on or read by blue light, preferably laser light |
| 02/24/2005 | DE10197268T5 Verfahren zur Reinigung von Tetrodotoxin A process for the purification of tetrodotoxin |
| 02/24/2005 | CA2534300A1 Aminopyrones and their use as atm inhibitors |
| 02/23/2005 | EP1508560A2 Substituted Phenylketoenols |
| 02/23/2005 | EP1507781A2 Process for preparing maytansinol |
| 02/23/2005 | EP1507778A1 Anti-tumour polycyclic carboxamides |
| 02/23/2005 | EP1507776A1 2-oxo-1,3,4-trihydroquinazolinyl derivatives for the treatment of cell proliferation-related disorders |
| 02/23/2005 | EP1507773A1 Macrocyclic compounds useful as pharmaceuticals |
| 02/23/2005 | EP1507765A2 Methods and compositions for treatment of central and peripheral nervous system disorders and novel compounds useful therefor |
| 02/23/2005 | CN1585772A Chemokine receptor antagonists and methods of use thereof |
| 02/23/2005 | CN1585744A Process for the preparation of benazepril |
| 02/23/2005 | CN1585636A Use of endothelin receptor antagonists in the treatment of tumour diseases |
| 02/23/2005 | CN1583751A Chemical semi-synthetic process for high-purity 10-hydroxy-camptothecin |
| 02/23/2005 | CN1583750A Use of 2-3-methylen-dioxy dibenzo [a, g] quinolizine onium chloride in treatment of diabete |
| 02/23/2005 | CN1583749A Process for extracting amarylid alkaloid from natural plant |
| 02/23/2005 | CN1190438C Nabufulin polybasic ester derivative and its production method |
| 02/22/2005 | US6858741 Use as pesticides and herbicides |
| 02/22/2005 | US6858640 Tricyclic indole compounds having affinity for serotonin receptor |
| 02/22/2005 | US6858621 Mbreast and prostate anticancer agents; viricides; alopecia |
| 02/22/2005 | US6858607 7,8-fused 4H-chromene and analogs as activators of caspases and inducers of apoptosis and the use thereof |
| 02/22/2005 | US6858605 Substituted 2,3-benzodiazepine derivatives |
| 02/22/2005 | CA2093078C 2-substituted tertiary carbinol derivatives of 1,5-iminosugars |
| 02/22/2005 | CA2093077C 2- and 3-amino and azido derivatives of 1,5-iminosugars |
| 02/17/2005 | WO2005015214A1 Novel chemiluminescent compounds and their use |
| 02/17/2005 | WO2005014517A2 Novel dibenzo[b,f]oxepine-10-carboxamides and pharmaceutical uses thereof |
| 02/17/2005 | WO2005013998A1 Quinazoline derivatives as inhibitors of vegf receptor tyrosine kinases |
| 02/17/2005 | WO2005013903A2 Derivatives of substituted quinone and uses thereof |
| 02/17/2005 | WO2004111056A3 Compound libraries of spiro-benzodioxine-piperidines |
| 02/17/2005 | WO2004093781A3 Podophyllotoxin derivatives as igf-1r inhibitors |
| 02/17/2005 | US20050038247 topoisomerase inhibitors such as [5-(4-Cyclopropylcarbamoyl-imidazol-1-yl)-7-pyrimidin-2-yl-1H-benzoimidazol-2-yl]-carbamic acid ethyl ester, used for prophylaxis of bacterial infections in mammals |
| 02/17/2005 | US20050038088 N-sulfonylheterocyclopyrrolyl-alkylamine compounds as 5-hydroxytryptamine-6 ligands |
| 02/17/2005 | US20050038086 Epothilone derivatives and methods for making and using the same |
| 02/17/2005 | US20050038067 A compound with azo containing mono and a bicyclic rings attached with an aryl or heteroaryl ring; both therapeutic and diagnostic |
| 02/17/2005 | US20050038064 Anticarcinogenic agents; breast, colon, lung, prostate, ovarian, and gastric cancers, leukemia, melanomas; (5R)-5-ethyl-9,10-difluoro-5-hydroxy-4,5,13,15-tetrahydro-1H,3H-oxepino[3',4':6,7]indolizino[1,2-b]quinoline-3,15-dione |
| 02/17/2005 | US20050038060 Spiropoperidine compounds as ligands for orl-1 receptor |
| 02/17/2005 | US20050038023 Inhibitors of glycogen synthase kinase-3 (gsk-3) and aurora-2, both serine/threonine protein kinases; for treating diseases such as cancer, diabetes and alzheimer's disease |
| 02/17/2005 | US20050038021 2,4,5,-trisubstituted phenylketo-enols for use as pesticides and herbicides |
| 02/17/2005 | CA2534422A1 Quinazoline derivatives as inhibitors of vegf receptor tyrosine kinases |
| 02/17/2005 | CA2533174A1 Novel dibenzo[b,f]oxepine-10-carboxamides and pharmaceutical uses thereof |
| 02/16/2005 | EP1506962A2 Nitrogen-containing aromatic heterocycles |
| 02/16/2005 | EP1506960A1 Indole compounds as inhibitors of tubulin polymerisation for the treatment of angiogenesis-related disorders |
| 02/16/2005 | EP1506959A2 Derivatised molecules for mass spectrometry |
| 02/16/2005 | EP1506202A1 1-aza-dibenzoazulenes as inhibitors of tumour necrosis factor production and intermediates for the prepartion thereof |
| 02/16/2005 | EP1506201A1 R-enantiomers of pyranoindole derivatives for treatment of hepatitis c |
| 02/16/2005 | EP1506197A1 Acyl bicyclic derivatives of pyrrol |
| 02/16/2005 | EP1506188A1 Process for the preparation of a hydrate of an anthranilic acid derivative |
| 02/16/2005 | EP1506175A1 N-substituted tricyclic 3-aminopyrazoles as pdgf receptor inhibitors |
| 02/16/2005 | EP1505963A1 Hepatitis c virus inhibitors |
| 02/16/2005 | EP1064285B1 Novel cephalotaxane derivatives and process for their preparation |
| 02/16/2005 | CN1580057A 20(S) camptotheca alkaloid derivatives, their preparing methods and uses |
| 02/16/2005 | CN1189466C New direct chain or cyclic urea, its preparing method and medicinal composition containing them |
| 02/15/2005 | US6855843 Antihistamines; rheumatic diseases; antidiabetic agents; inflammatory bowel disorders |
| 02/15/2005 | US6855821 Processes for preparing 1,3-dioxolane nucleosides |
| 02/15/2005 | US6855720 Nitrogen-based camptothecin derivatives |
| 02/15/2005 | CA2312409C New derivatives of 7-oxo-2,3,7,14-tetrehydro-1h-benzo[b]pyrano[3,2-h]acridine carboxylate, the procedure for preparing same and the pharmaceutical compounds containing same |
| 02/10/2005 | WO2005012436A1 Triangulenium fluorescent dyes and polymers comprising such dyes |
| 02/10/2005 | WO2005012332A1 Spatially-defined macrocycles incorporating peptide bond surrogates |
| 02/10/2005 | WO2005012311A1 N-sulfonylheterocyclopyrrolylalkylamine compounds as 5-hydroxytryptamine-6 ligands |
| 02/10/2005 | WO2005012292A1 Gyrase inhibitors and uses thereof |
| 02/10/2005 | WO2005012257A1 Indazole derivatives |
| 02/10/2005 | WO2004093856A3 Combination of a cox-2 inhibitor and an alkylating-type antineoplastic agent for treatment of neoplasia |
| 02/10/2005 | US20050033048 Spiro[isobenzofuran-1,4'-piperidin]-3-ones and 3h-spiroisobenzofuran-1,4'-piperidines |
| 02/10/2005 | US20050032886 Use of parthenolide derivatives as antileukemic and cytotoxic agents |
| 02/10/2005 | US20050032885 Use as pesticides, microbicides and herbicides; compatible with crop plants |
| 02/10/2005 | US20050032832 Substituted 2-phenyl-4-quinolone-3-carboxylic acid compounds and their use as antitumor agents |
| 02/10/2005 | US20050032820 Novel spiro compounds |
| 02/10/2005 | US20050032817 Kinesin spindle protein (KSP) inhibitors, e.g., 3-benzyl-2-(1-{(4-bromobenzyl)[2-(dimethylamino)ethyl]amino}propyl)furo[2,3-d]pyrimidin-4(3H)-one; antiproliferative and -carcinogenic agents; side effects reduction; cancers of the brain, genitourinary tract, lymphatic system, stomach, larynx and lung |
| 02/10/2005 | US20050032794 For example, 2-Dimethylamino-N-(3-dimethylamino-1,4-dioxo-1,4-dihydro-naphthalen-2-yl)-N-methyl-acetamide; ability to function as gene expression modulators for genes found in cancer cells, especially genes involved in misregulated signal transduction pathways typical of cancers of colon and breast |
| 02/10/2005 | US20050032724 Multidrug Resistance Protein 1 (MRP1); mutagenesis |
| 02/10/2005 | US20050032147 Chemiluminescent acridinum compounds and analogues thereof as substrates of hydrolytic enzymes |
| 02/10/2005 | DE10197267T5 Eine Methode zur Extraktion von Tetrodotoxin A method for extraction of tetrodotoxin |